These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28250328)

  • 1. [Local Pharmacy Pharmacists' Responses to the Prescription of Drugs That Influence Driving].
    Nagata T; Yamada J; Oohara H; Kizu J
    Yakugaku Zasshi; 2017; 137(3):323-328. PubMed ID: 28250328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patients Taking Antihistamines and Their Effects on Driving].
    Kizu J
    Yakugaku Zasshi; 2017; 137(3):315-321. PubMed ID: 28250327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacists' Advice about Driving for Diabetic Patients].
    Satake M
    Yakugaku Zasshi; 2017; 137(3):329-335. PubMed ID: 28250329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innvestigation on patient's and pharmacist's attitudes toward medical services in community pharmacies.
    Sakurai H; Konno H; Shimamori Y; Sugiyama H; Yoshimachi M; Kouno H; Gotou T; Hayase Y
    Yakugaku Zasshi; 2009 May; 129(5):557-68. PubMed ID: 19420886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of chronic pain patients' psychotropic drug knowledge and warning labels on the decision whether to drive a car or not.
    Veldhuijzen DS; van Wijck AJ; Verster JC; Kalkman CJ; Kenemans JL; Olivier B; Volkerts ER
    Traffic Inj Prev; 2006 Dec; 7(4):360-4. PubMed ID: 17114093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic study to establish medication safety culture with patient-commitment style in community pharmacy: An examination from meeting reports].
    Onda M; Okuda N; Kosaka N; Takahashi N; Matsuura M; Yamaguchi Y; Yamada R
    Yakugaku Zasshi; 2007 Dec; 127(12):2075-8. PubMed ID: 18057796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to multilingual prescription labels and verbal translation services in California.
    Zargarzadeh AH; Law AV
    Res Social Adm Pharm; 2011 Dec; 7(4):338-46. PubMed ID: 21272528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative.
    Krueger KP; Felkey BG; Berger BA
    J Am Pharm Assoc (2003); 2003; 43(6):668-78; quiz 678-9. PubMed ID: 14717263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicines and driving: evaluation of training and software support for patient counselling by pharmacists.
    Legrand SA; Boets S; Meesmann U; Verstraete AG
    Int J Clin Pharm; 2012 Aug; 34(4):633-43. PubMed ID: 22678812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Counselling customers with psychotropic vs. cardiovascular prescriptions: a survey among Austrian community pharmacists].
    Hagmair G; Amering M; Kaiser G; Katschnig H
    Neuropsychiatr; 2014; 28(4):178-84. PubMed ID: 25199924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishing a System for Effectively Explaining Indications for Driving Prohibition Contained in Drug Package Inserts].
    Tanaka M
    Yakugaku Zasshi; 2017; 137(3):337-340. PubMed ID: 28250330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of patients' and pharmacists' satisfaction with medication counseling provided by community pharmacies: a cross-sectional survey.
    Yang S; Kim D; Choi HJ; Chang MJ
    BMC Health Serv Res; 2016 Apr; 16():131. PubMed ID: 27080704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting poor counselling about prescription medicines in Swedish community pharmacies.
    Tully MP; Beckman-Gyllenstrand A; Bernsten CB
    Patient Educ Couns; 2011 Apr; 83(1):3-6. PubMed ID: 20605395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do no harm: the role of community pharmacists in regulating public access to prescription drugs in Saudi Arabia.
    Bahnassi A
    Int J Pharm Pract; 2016 Apr; 24(2):142-5. PubMed ID: 26383607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China.
    Fang Y; Yang S; Feng B; Ni Y; Zhang K
    Health Soc Care Community; 2011 Mar; 19(2):189-97. PubMed ID: 20880089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist self-reported antidepressant medication counseling.
    Cannon-Breland ML; Westrick SC; Kavookjian J; Berger BA; Shannon DM; Lorenz RA
    J Am Pharm Assoc (2003); 2013; 53(4):390-9. PubMed ID: 23892812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' attitude toward dispensing pharmacies: questionnaire survey conducted August 15.
    Ooe Y; Tabuse S; Akano T
    Jpn Hosp; 2004 Jul; (23):40-3. PubMed ID: 19195254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.